Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial

International Journal of Cardiology

Volumn 209, Issue , 2016, Pages 310-316

  Abdul Rahim, Azmil H ^a   Macisaac, Rachael L ^a   Jhund, Pardeep S ^a   Petrie, Mark C ^b   Lees, Kennedy R ^a   McMurray, John J V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

Author keywords

Diabetes; Digoxin; Heart failure; Outcome

Indexed keywords

CREATININE; DIGOXIN; PLACEBO; POTASSIUM; CARDIOTONIC AGENT; DIGITALIS;

ADULT; AGE; ARTICLE; CARDIOVASCULAR MORTALITY; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIGITALIS INTOXICATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GENDER; HEART DEATH; HEART FAILURE; HEART FAILURE WITH REDUCED EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPERKALEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; AGED; CHEMICALLY INDUCED; CLINICAL TRIAL; DRUG EFFECTS; HEART STROKE VOLUME; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; TRENDS;

AGED; CARDIOTONIC AGENTS; DIABETES MELLITUS; DIGITALIS; DIGOXIN; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; HYPERKALEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84961684158     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.02.074     Document Type: Article

References (15)

1. A. Dei Cas, S.S. Khan, J. Butler, R.J. Mentz, R.O. Bonow, A. Avogaro, and et al. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure JACC Heart Fail 3 2015 136 145
2. A. Dei Cas, G.C. Fonarow, M. Gheorghiade, and J. Butler Concomitant diabetes mellitus and heart failure Curr Probl Cardiol 40 2015 7 43
3. M.R. MacDonald, M.C. Petrie, N.M. Hawkins, J.R. Petrie, M. Fisher, R. McKelvie, and et al. Diabetes, left ventricular systolic dysfunction, and chronic heart failure Eur Heart J 29 2008 1224 1240
4. N. Suskin, R.S. McKelvie, R.J. Burns, R. Latini, D. Pericak, J. Probstfield, and et al. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur Heart J 21 2000 1368 1375
5. M.R. MacDonald, M.C. Petrie, F. Varyani, J. Ostergren, E.L. Michelson, J.B. Young, and et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in Heart failure: assessment of reduction in mortality and morbidity (CHARM) programme Eur Heart J 29 2008 1377 1385
6. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., M.H. Drazner, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
7. McMurray JJ, S. Adamopoulos, Anker SD, A. Auricchio, M. Böhm, K. Dickstein, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
8. Digitalis Investigation Group Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure Control Clin Trials 17 1996 77 97
9. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
10. M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, and et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme Lancet 362 2003 759 766
11. F. Zannad, J.J. McMurray, H. Krum, D.J. van Veldhuisen, K. Swedberg, H. Shi, and et al. Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
12. K. Swedberg, M. Komajda, M. Böhm, J.S. Borer, I. Ford, A. Dubost-Brama, and et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
13. J.J. McMurray, M. Packer, A.S. Desai, J. Gong, M.P. Lefkowitz, A.R. Rizkala, and et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure N Engl J Med 371 2014 993 1004
14. O.J. Ziff, D.A. Lane, M. Samra, M. Griffith, P. Kirchhof, G.Y.H. Lip, and et al. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data BMJ 351 2015 h4451
15. S. Ather, L.E. Peterson, V.G. Divakaran, A. Deswal, K. Ramasubbu, I. Giorgberidze, and et al. Digoxin treatment in heart failure - unveiling risk by cluster analysis of DIG data Int J Cardiol 150 2011 264 269